Predicting solute transfer rate in patients initiating peritoneal dialysis

David A. Jaques,Andrew Davenport
DOI: https://doi.org/10.1007/s40620-023-01862-y
IF: 4.4061
2024-02-01
Journal of Nephrology
Abstract:While assessment of membrane characteristics is fundamental to peritoneal dialysis (PD) prescription in patients initiating therapy, peritoneal equilibration test has theoretical and practical drawbacks. We wished to determine whether an equation using simple clinical variables could predict fast (above population mean) peritoneal solute transfer rate without dialysate sampling.
urology & nephrology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to predict the peritoneal solute transport rate (PSTR) in patients starting peritoneal dialysis (PD) treatment through simple clinical variables without performing the peritoneal equilibration test (PET). Specifically, the researchers hope to develop an equation based on simple clinical variables to predict whether the patient's PSTR is higher than the population average (i.e., fast transporters), thereby guiding PD prescriptions without the need to collect dialysate samples. ### Background Evaluating peritoneal characteristics is crucial for patients starting peritoneal dialysis (PD) treatment. However, the traditional peritoneal equilibration test (PET) has theoretical and practical limitations, such as difficulty in standardization, inaccurate measurement, heavy nursing burden, and high economic cost. Therefore, the researchers hope to predict the patient's PSTR through simple clinical variables, thereby avoiding the use of PET. ### Methods The researchers consecutively included patients who had recently started PD treatment and had their first clinical follow - up within 3 months in a tertiary hospital. The PSTR was measured through a 4 - hour peritoneal equilibration test. The researchers generated an equation based on simple clinical variables in a randomly selected modeling group and tested the performance of this equation in another independent validation group. ### Results A total of 712 patients were included in the study, of which 562 were used for modeling and 150 for validation. The average age of the patients was 58.4 ± 15.9 years, and 60.5% were male. The average value of PSTR was 0.73 ± 0.13. The area under the ROC curve (AUC) of the equation based on gender, race, serum sodium, and albumin in detecting PSTR higher than 0.73 (fast transporters) was 0.74 (95% CI: 0.67 - 0.82). Based on the estimated PSTR values at the 15th percentile (> 0.66), 20th percentile (> 0.68), 25th percentile (> 0.69), and 30th percentile (> 0.70), fast transporters could be excluded with negative predictive values of 100%, 93.5%, 84.2%, and 80.0% respectively. ### Conclusion The equation based on simple clinical variables can reliably exclude fast transporters among newly - started PD treatment patients without the need to collect dialysate samples. This is of great significance for guiding PD prescriptions in daily clinical practice, especially in resource - limited settings.